Table 2. The linear correlations of cfDNA and clinical parameters.
| Variables | cfDNA (μg/mL) | |
|---|---|---|
| Pearson correlation coefficient | P value | |
| PLT (109/L) | −0.18 | 0.227 |
| Albumin (g/L) | −0.41 | 0.004 |
| Total bilirubin (μmol/L) | 0.07 | 0.629 |
| Direct bilirubin (μmol/L) | 0.11 | 0.447 |
| ALT (U/L) | 0.13 | 0.382 |
| AST (U/L) | 0.23 | 0.121 |
| PT (s) | 0.35 | 0.015 |
| Tumor diameter (cm) | 0.51 | 0.0002 |
| MELD score | 0.18 | 0.220 |
cfDNA, circulating cell-free DNA; PLT, platelet; ALT, Alanine transaminase; AST, glutamic oxaloacetic transaminase; PT, prothrombin time; MELD, Model for end-stage liver disease.